Revolution Medicines, Inc.RVMDNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-677.70M
↓ 200% below average
Average (7y)
$-225.52M
Historical baseline
Range
High:$-29.84M
Low:$-677.70M
CAGR
+56.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-677.70M | -41.8% |
| 2023 | $-477.88M | -92.2% |
| 2022 | $-248.62M | -38.3% |
| 2021 | $-179.75M | -76.4% |
| 2020 | $-101.91M | -109.7% |
| 2019 | $-48.59M | -21.7% |
| 2018 | $-39.91M | -33.8% |
| 2017 | $-29.84M | - |